Telmisartan
This medication belongs to the angiotensin receptor blocker (ARB) class and is used to treat high blood pressure and to reduce the risk of heart attack and stroke in high-risk patients. It works by blocking the action of a hormone called angiotensin II, which normally tightens blood vessels. It is taken once daily and is generally well tolerated.
Молекулярная масса
514,6230 g/mol
LogP
6,90
TPSA
72,90 Ų
Правило пяти Липинского
Не соответствует
Терапевтические области
Классы препаратов
Механизм действия
Selective angiotensin II type 1 receptor antagonist; also a partial PPAR-gamma agonist.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Selective angiotensin II type 1 receptor antagonist; also a partial PPAR-gamma agonist.
2D Структура
Cite this structure
Embed this structure
SMILES
CCCc1nc2c(C)cc(-c3nc4ccccc4n3C)cc2n1Cc1ccc(-c2ccccc2C(=O)O)cc1
InChI
InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)
Molecular Formula
C33H30N4O2
HBD / HBA
1 / 4
Вращаемые Связи
7
Тяжёлые Атомы
39
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Часто задаваемые вопросы
This medication belongs to the angiotensin receptor blocker (ARB) class and is used to treat high blood pressure and to reduce the risk of heart attack and stroke in high-risk patients. It works by blocking the action of a hormone called angiotensin II, which normally tightens blood vessels. It is taken once daily and is generally well tolerated.
Selective angiotensin II type 1 receptor antagonist; also a partial PPAR-gamma agonist.
Key pharmacokinetic parameters for Telmisartan: Half-life: 24 hours.
Yes, Telmisartan is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
Related Drugs
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1017. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 65999. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Медицинский отказ от ответственности
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="telmisartan"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/telmisartan/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/telmisartan/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/telmisartan/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="telmisartan"></drugfyi-drug>